Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colorectal Cancer Metastatic × IFL protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 9 Rectal Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Colonic Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Margins of Excision 1 Colorectal Cancer Metastatic 1

Interventions

Bevacizumab 2 aflibercept 1 XELOX 1 Vemurafenib 1 Panitumumab 1 Irinotecan 1 IFL protocol 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01571284 2018-04-17

Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Sanofi

Phase 3 Completed

781 enrolled 28 charts

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡